2026 NPPES data Colon & Rectal Surgery Physician NPI 1568569655 M.D.
Verify on CMS →

FAROUK TOOTLA, M.D.

Colon & Rectal Surgery Physician in BLOOMFIELD HILLS, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
155
Medicare Part D claims · 62 beneficiaries · Colon & Rectal Surgery Physician avg: 196
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$15.65
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

FAROUK TOOTLA, M.D. filed 155 Medicare Part D claims in 2023 as a Colon & Rectal Surgery Physician in BLOOMFIELD HILLS, Michigan, prescribing 92% generic.

155
Part D claims, 2023
92%
generic prescribing
$15.65
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

FAROUK TOOTLA, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

155 35th percentile higher than 35% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). This entry sits in this band. 200–400: 182,923 prescribers (13%). Above this entry. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

FAROUK TOOTLA, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about FAROUK TOOTLA, M.D.?

Quality data not reported

NPI registry status

Active

Issued 09/20/2006

NPI 1568569655

Primary specialty

Colon & Rectal Surgery Physician

Niche

1,608 US NPIs in this specialty

Medicare Part D claims

155 21% vs specialty avg

2023 prescription claims

Specialty avg: 196

Specialty distribution in Michigan

How Colon & Rectal Surgery Physician compares to other specialties among Michigan providers

Michigan providers

Colon & Rectal Surgery Physician share within Michigan

1. Colon & Rectal Surgery Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Colon & Rectal Surgery Physician share within Michigan

Specialty board-certification context

Estimated specialty board-certified rate — Colon & Rectal Surgery Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Colon & Rectal Surgery Physician ABMS/AOA estimate

Est. board-certified rate (Colon & Rectal Surgery Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Colon & Rectal Surgery Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

FAROUK TOOTLA, M.D. appears in the CMS NPPES registry as a Colon & Rectal Surgery Physician provider holding M.D. credentials at 44060 WOODWARD AVE, BLOOMFIELD HILLS, MI, 48302, with a listed phone of (248) 334-3197. NPI 1568569655 was issued on 09/20/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what TOOTLA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 155 prescription claims written by this provider, covering 62 Medicare beneficiaries and totaling roughly $19K in drug spend, split 8% brand-name and 92% generic by claim count, with an opioid prescribing rate of 9.7%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Colon & Rectal Surgery Physician is a narrow specialty nationwide, with 1,608 enrolled providers across 50 states and an average of 196 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

44060 WOODWARD AVE
BLOOMFIELD HILLS, MI 48302

Provider Details

NPI 1568569655
Specialty Colon & Rectal Surgery Physician
Credentials M.D.
Gender Male
NPI Issued 09/20/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for FAROUK TOOTLA, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$16

Largest payer

Takeda Pharmaceuticals U.S.A., Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Michigan MI-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to FAROUK TOOTLA, M.D.. To verify FAROUK TOOTLA, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

123
Total board actions, Michigan 2023
Across 120 cases
3.00
Actions per 1,000 licensees
Michigan statewide rate
probation
Most common action type
44 cases

MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

FAROUK TOOTLA, M.D. — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 155 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

155
Total Claims
$19K
Total Drug Cost
62
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
280
Total Day Supply
7,358
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$7K
Generic Drug Cost
$12K
Opioid Claims
15 (9.7% rate)
Antibiotic Claims
18

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.37
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What FAROUK TOOTLA, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Dicyclomine Hcl
21
Budesonide Ec
Budesonide
15
Omeprazole
12
Hydrocortisone
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Colon & Rectal Surgery Physician Overview

How FAROUK TOOTLA, M.D. fits within the Colon & Rectal Surgery Physician landscape nationally.

1,608
Colon & Rectal Surgery Physician Providers in US
50
States with Colon & Rectal Surgery Physician
196
Avg Claims per Provider

FAROUK TOOTLA, M.D.'s 155 claims are below the specialty average of 196.

Nearby Colon & Rectal Surgery Physician Providers in Michigan

Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as TOOTLA.

Compare Colon & Rectal Surgery Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is FAROUK TOOTLA, M.D.'s specialty?
FAROUK TOOTLA, M.D. specializes in Colon & Rectal Surgery Physician and practices in BLOOMFIELD HILLS, Michigan. Credentials: M.D..
How much does FAROUK TOOTLA, M.D. prescribe under Medicare Part D?
In 2023, FAROUK TOOTLA, M.D. wrote 155 Medicare Part D claims totaling $19K in drug costs for 62 beneficiaries.
Where is FAROUK TOOTLA, M.D. located?
FAROUK TOOTLA, M.D. is located at 44060 WOODWARD AVE, BLOOMFIELD HILLS, MI, 48302. Phone: (248) 334-3197.
What is FAROUK TOOTLA, M.D.'s NPI number?
FAROUK TOOTLA, M.D.'s National Provider Identifier (NPI) is 1568569655, issued on 09/20/2006.
Does FAROUK TOOTLA, M.D. prescribe more brand-name or generic drugs?
FAROUK TOOTLA, M.D.'s prescribing is 8% brand-name and 92% generic drugs by claim count, with $7K in brand drug costs.
Does FAROUK TOOTLA, M.D. prescribe opioids?
Yes, FAROUK TOOTLA, M.D. had 15 opioid claims in 2023 with an opioid prescribing rate of 9.7%.
How many Colon & Rectal Surgery Physician providers are there in the US?
There are 1,608 Colon & Rectal Surgery Physician providers across 50 states in the US. The average Colon & Rectal Surgery Physician provider writes 196 Medicare Part D claims per year.
What drugs does FAROUK TOOTLA, M.D. prescribe most often?
Based on 2023 Medicare Part D data, FAROUK TOOTLA, M.D.'s most frequently prescribed drugs include Dicyclomine Hcl, Budesonide Ec, Omeprazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does FAROUK TOOTLA, M.D. accept Medicare?
FAROUK TOOTLA, M.D. appears in CMS Medicare data with 155 Part D claims and 62 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify FAROUK TOOTLA, M.D.'s credentials?
FAROUK TOOTLA, M.D.'s NPI is 1568569655 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology